Search

This article provides a review and comparison of the new National Institute for Health and Care Excellence (NICE) guidance for hypertension with guidelines from the United States (US) and Europe. The NICE and European guidelines recommend diagnosing hypertension at a higher level than the American guidelines. NICE suggests less stringent targets for treatment compared to both the American and European guidelines, while using similar treatment regimens. The article also highlights differences in interpretation of data for setting targets, interventions, drug therapy, and non-pharmacological therapy between these guidelines. The text discusses the differences in guidelines for the treatment of hypertension between various organizations, including NICE, ESC/ESH, and ACC/AHA. One major difference is the recommendation for single agent therapy versus two agents as the first step. The guidelines also differ in their recommendations for non-pharmacological interventions such as weight loss, exercise, alcohol intake, and dietary changes. The text highlights the influence of the Systolic Blood Pressure Intervention Trial (SPRINT) on the guidelines and the varying interpretations of its results. Additionally, the text mentions the lack of specific advice for BP management in the elderly population and the focus on frailty as a guide for treatment. Overall, the text emphasizes the importance of hypertension management and the ongoing updates and revisions in guidelines. [Extracted from the article]

Artificial Intelligence (AI) carries the potential for unprecedented disruption in radiology, with possible positive and negative consequences. The integration of AI in radiology holds the potential to revolutionize healthcare practices by advancing diagnosis, quantification, and management of multiple medical conditions. Nevertheless, the ever-growing availability of AI tools in radiology highlights an increasing need to critically evaluate claims for its utility and to differentiate safe product offerings from potentially harmful, or fundamentally unhelpful ones.This multi-society paper, presenting the views of Radiology Societies in the USA, Canada, Europe, Australia, and New Zealand, defines the potential practical problems and ethical issues surrounding the incorporation of AI into radiological practice. In addition to delineating the main points of concern that developers, regulators, and purchasers of AI tools should consider prior to their introduction into clinical practice, this statement also suggests methods to monitor their stability and safety in clinical use, and their suitability for possible autonomous function. This statement is intended to serve as a useful summary of the practical issues which should be considered by all parties involved in the development of radiology AI resources, and their implementation as clinical tools.Key points • The incorporation of artificial intelligence (AI) in radiological practice demands increased monitoring of its utility and safety.• Cooperation between developers, clinicians, and regulators will allow all involved to address ethical issues and monitor AI performance.• AI can fulfil its promise to advance patient well-being if all steps from development to integration in healthcare are rigorously evaluated., (© 2024. The Author(s).)